Apolipoprotein L1 (APOL1) is associated with increased incidence of chronic kidney disease (CKD) and end-stage renal disease, and with faster progression of CKD, in African Americans. APOL1 is expressed in intra- and extrarenal vascular tissue, making it a candidate to explain the increased incidence of cardiovascular disease in CKD. This Commentary discusses the disparate results from three studies showing that APOL1 renal risk genotypes are either harmful, neutral, or protective in the context of cardiovascular disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/ki.2014.319 | DOI Listing |
Publication Analysis
Top Keywords
increased incidence
8
disease ckd
8
cardiovascular disease
8
apolipoprotein obscurity
4
obscurity consistency
4
consistency controversy
4
controversy apolipoprotein
4
apolipoprotein apol1
4
apol1 associated
4
associated increased
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!